Sort by:
2531 products
2531 products
INNOVAIR NEXTHALER (BECLOMETASONA/FORMOTEROL) 100 mcg/6 mcg 120 DOSES
Active ingredient: Beclomethasone / Formoterol
Concentration: 100 mcg / 6 mcg per dose
Presentation: 120 doses, inhalation powder (Nexthaler)
Laboratory: Chiesi
Origin: Made in Mexico
Combined dry powder inhaler indicated for the regular treatment of asthma and COPD. Beclomethasone acts as an anti-inflammatory corticosteroid and formoterol as a long-acting bronchodilator, working together to reduce bronchial inflammation, keep airways open, and prevent exacerbations.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
VALTROVER M (MONTELUKAST) 5 mg 30 CHEWABLE TABLETS
Active ingredient: Montelukast
Concentration: 5 mg
Presentation: 30 chewable tablets
Laboratory: Maver
Origin: Made in Mexico
Leukotriene receptor antagonist in chewable form, indicated for children and adolescents with chronic asthma and allergic rhinitis. It blocks the action of leukotrienes, reducing airway inflammation and preventing asthma attacks. Its chewable presentation facilitates adherence to pediatric treatment.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
SENLOIR (MONTELUKAST) 10 mg 20 TABLETS
Active ingredient: Montelukast
Concentration: 10 mg
Presentation: 20 tablets
Manufacturer: Collins
Origin: Made in Mexico
Leukotriene receptor antagonist indicated for the management of asthma and the relief of seasonal and perennial allergic rhinitis. It inhibits the effects of leukotrienes, reducing airway inflammation, improving lung function, and preventing asthma attacks and nasal congestion.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
KATSORAAM (MONTELUKAST) 10 mg 30 TABLETS
Active substance: Montelukast
Concentration: 10 mg
Presentation: 30 tablets
Laboratory: Raam
Origin: Made in Mexico
Leukotriene receptor antagonist indicated for the treatment of chronic asthma and allergic rhinitis symptoms in adults. It blocks leukotrienes, reducing inflammation and airway narrowing for sustained control of respiratory and allergic symptoms.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
ONTRONON (MONTELUKAST) 5 mg 30 TABLETS
Active substance: Montelukast
Concentration: 5 mg
Presentation: 30 chewable tablets
Laboratory: Raam
Origin: Made in Mexico
Leukotriene receptor antagonist indicated for the control of asthma in older children and adolescents, and the relief of allergic rhinitis symptoms. Reduces airway inflammation and prevents bronchial spasms for a better quality of life in pediatric patients with respiratory conditions.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
VALTROVER (MONTELUKAST) 10 mg 20 TABLETS
Active ingredient: Montelukast
Concentration: 10 mg
Presentation: 20 tablets
Laboratory: Maver
Origin: Made in Mexico
Leukotriene receptor antagonist indicated for the treatment and prevention of asthma in adults and the relief of allergic rhinitis. It blocks leukotrienes, reducing inflammation and airway narrowing to improve breathing and reduce asthmatic episodes.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
SINGULAIR (MONTELUKAST) 10 mg 30 TABLETS
Active substance: Montelukast
Concentration: 10 mg
Presentation: 30 tablets
Laboratory: Merck
Origin: Made in Mexico
Original brand-name medication with montelukast, a leukotriene receptor antagonist, indicated for the control of chronic asthma and the relief of seasonal and perennial allergic rhinitis in adults. It blocks leukotrienes, improving lung function and preventing wheezing and shortness of breath.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before taking any medication.
VALTROVER G (MONTELUKAST) 4 mg 10 GRANULATED SACHETS
Active ingredient: Montelukast
Concentration: 4 mg
Presentation: 10 granulated sachets
Laboratory: Maver
Origin: Made in Mexico
Leukotriene receptor antagonist in granulated presentation, indicated for the prevention and treatment of asthma and allergic rhinitis in young children (2–5 years). It reduces airway inflammation and facilitates administration in pediatric doses as it can be mixed with soft foods or liquids.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
MONTELUKAST (AMSA) 10 mg 20 TABLETS
Active substance: Montelukast
Concentration: 10 mg
Presentation: 20 tablets
Laboratory: Amsa
Origin: Made in Mexico
Leukotriene receptor antagonist indicated for the prevention and treatment of chronic asthma and the relief of seasonal and perennial allergic rhinitis in adults. It reduces inflammation and bronchial constriction, improving respiratory function and controlling airway symptoms.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your physician before consuming any medication.
MONTELUKAST (CAMBER) 10 mg 30 TABLETS
Active ingredient: Montelukast
Strength: 10 mg
Presentation: 30 tablets
Laboratory: Camber
Origin: Made in Mexico
Leukotriene receptor antagonist indicated for the prevention and treatment of chronic asthma and the relief of seasonal and perennial allergic rhinitis in adults. Reduces inflammation and bronchial constriction, improving respiratory function and controlling airway symptoms.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
TRELEGY (FLUTICASONE/UMECLIDINIUM/VILANTEROL) 100 mcg/62.5 mcg/25 mcg 30 DOSES
Active ingredient: Fluticasone / Umeclidinium / Vilanterol
Concentration: 100 mcg / 62.5 mcg / 25 mcg per dose
Presentation: 30 doses, dry powder inhaler (Ellipta)
Laboratory: GlaxoSmithKline
Origin: Made in Mexico
Triple combination inhaler indicated for the maintenance treatment of COPD. Fluticasone acts as an anti-inflammatory corticosteroid, umeclidinium as a LAMA anticholinergic, and vilanterol as a LABA long-acting beta-2 agonist, offering comprehensive management of bronchial obstruction and inflammation in a single device.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
RELVARE (FLUTICASONE FUROATE/VILANTEROL) 100 mcg/25 mcg 30 DOSES
Active ingredient: Fluticasone Furoate / Vilanterol
Concentration: 100 mcg / 25 mcg per dose
Presentation: 30 doses, inhalation powder (Ellipta)
Laboratory: GlaxoSmithKline
Origin: Made in Mexico
Once-daily, single-inhalation ICS+LABA combination inhaler indicated for the maintenance treatment of asthma and COPD. Fluticasone furoate acts as an anti-inflammatory corticosteroid and vilanterol as a long-acting beta-2 agonist, improving lung function and controlling respiratory symptoms long-term.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
MONTELUKAST (AMSA) 10 mg 20 TABLETS
Active substance: Montelukast
Concentration: 10 mg
Presentation: 20 tablets
Laboratory: Amsa
Origin: Made in Mexico
Leukotriene receptor antagonist indicated for the prevention and treatment of chronic asthma and the relief of seasonal and perennial allergic rhinitis in adults. It reduces inflammation and bronchial constriction, improving respiratory function and controlling airway symptoms.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your physician before consuming any medication.
MONTELUKAST (IMPLEMEDIX) 10 mg 30 TABLETS
Active ingredient: Montelukast
Concentration: 10 mg
Presentation: 30 tablets
Laboratory: Implemedix
Origin: Made in Mexico
Leukotriene receptor antagonist indicated for the prevention and treatment of chronic asthma and the relief of seasonal and perennial allergic rhinitis in adults. It reduces inflammation and bronchial constriction, improving respiratory function and controlling airway symptoms.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before taking any medication.

{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>